Search Results
Jul 21, 2026, 06:17 ET ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securities Fraud Class Action
investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-6918.Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued
More news about: Bleichmar Fonti & Auld LLP
Jul 20, 2026, 03:31 ET ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: DJS Law Group LLP
Jul 20, 2026, 02:25 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: The Schall Law Firm
Jul 17, 2026, 22:30 ET ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 17, 2026, 22:00 ET ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
ADMA Biologics, Inc. ("ADMA" or the "Company") (NasdaqGM: ADMA) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Jul 17, 2026, 04:00 ET ADMA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead ADMA Biologics Class Action Lawsuit
lawsuit. Captioned Mazzarino v. ADMA Biologics, Inc., No. 26-cv-06918 (D.N.J.), the ADMA Biologics class action lawsuit charges ADMA Biologics as well as certain of ADMA Biologics' top executive officers with violations of the Securities Exchange Act of 1934.
More news about: Robbins Geller Rudman & Dowd LLP
Jul 16, 2026, 12:21 ET NASDAQ: ADMA CLASS ACTION NOTICE: Berger Montague Encourages ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Inquire About a Securities Fraud Class Action
Berger Montague PC announces a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA" or the "Company") on behalf of investors who purchased or acquired ADMA common stock during the period from August 9, 2024 through March 25, 2026 (the "Class
More news about: Berger Montague
Jul 16, 2026, 10:09 ET ADMA DEADLINE: SueWallSt Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline
securities litigation firms in the United States.Frequently Asked Questions About the ADMA LawsuitQ: Who is eligible to join the ADMA investor lawsuit? A: Investors who purchased ADMA stock or securities between August 9, 2024 and March 25, 2026 and suffered financial losses may
More news about: SueWallSt.com
Jul 16, 2026, 10:09 ET ADMA DEADLINE: SueWallSt Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline
securities litigation firms in the United States.Frequently Asked Questions About the ADMA LawsuitQ: Who is eligible to join the ADMA investor lawsuit? A: Investors who purchased ADMA stock or securities between August 9, 2024 and March 25, 2026 and suffered financial losses may
More news about: SueWallSt.com
Jul 16, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMA
July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jul 15, 2026, 15:24 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA).
More news about: Glancy Prongay Wolke & Rotter LLP
Jul 15, 2026, 10:07 ET ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
recovered hundreds of millions of dollars for investors.Frequently Asked Questions About the ADMA LawsuitQ: Who are the defendants named in the ADMA lawsuit? A: The complaint names ADMA Biologics, Inc. and three individual defendants: CEO Adam S. Grossman, Vice Chairman Jerrold V.
More news about: Levi & Korsinsky, LLP
Jul 15, 2026, 10:07 ET ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
recovered hundreds of millions of dollars for investors.Frequently Asked Questions About the ADMA LawsuitQ: Who are the defendants named in the ADMA lawsuit? A: The complaint names ADMA Biologics, Inc. and three individual defendants: CEO Adam S. Grossman, Vice Chairman Jerrold V.
More news about: Levi & Korsinsky, LLP
Jul 14, 2026, 10:07 ET ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: The Gross Law Firm
Jul 14, 2026, 06:21 ET ADMA Court News: ADMA Biologics Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses
investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-6918.Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued
More news about: Bleichmar Fonti & Auld LLP
Jul 13, 2026, 04:40 ET ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
The DJS Law Group reminds investors of a class action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ:
More news about: DJS Law Group LLP
Jul 13, 2026, 03:26 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: The Schall Law Firm
Jul 12, 2026, 19:57 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 10, 2026, 22:00 ET ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
ADMA Biologics, Inc. (NasdaqGM: ADMA) ("ADMA" or the "Company"), if they purchased or otherwise acquired the Company's securities between August 9, 2024 and March 25, 2026,
More news about: ClaimsFiler
Jul 09, 2026, 17:23 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMA
July 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jul 09, 2026, 15:32 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
investors with losses related to ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA) have opportunity to lead
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jul 09, 2026, 08:30 ET INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
lawsuit. Captioned Mazzarino v. ADMA Biologics, Inc., No. 26-cv-06918 (D.N.J.), the ADMA Biologics class action lawsuit charges ADMA Biologics as well as certain of ADMA Biologics' top executive officers with violations of the Securities Exchange Act of 1934.
More news about: Robbins Geller Rudman & Dowd LLP
Jul 08, 2026, 10:11 ET Lost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Korsinsky, LLP highlights the contrast between ADMA Biologics, Inc.'s (NASDAQ: ADMA) public growth projections and the results alleged by independent research. A securities class action has been filed on behalf of investors who purchased ADMA securities between August 9, 2024 and March 25,
More news about: Levi & Korsinsky, LLP
Jul 07, 2026, 18:15 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 07, 2026, 15:22 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). IF
More news about: Law Offices of Howard G. Smith